154 related articles for article (PubMed ID: 8547463)
21. Exacerbation of schizophrenia associated with amantadine.
Nestelbaum Z; Siris SG; Rifkin A; Klar H; Reardon GT
Am J Psychiatry; 1986 Sep; 143(9):1170-1. PubMed ID: 2875665
[TBL] [Abstract][Full Text] [Related]
22. Effect of antipsychotic replacement with quetiapine on the symptoms and quality of life of schizophrenic patients with extrapyramidal symptoms.
Taniguchi T; Sumitani S; Aono M; Iga J; Kinouchi S; Aki H; Matsushita M; Taniguchi K; Tsuno M; Yamanishi K; Tomotake M; Kaneda Y; Ohmori T
Hum Psychopharmacol; 2006 Oct; 21(7):439-45. PubMed ID: 17029303
[TBL] [Abstract][Full Text] [Related]
23. Phenothiazine-induced decompensation.
Van Putten T; Mutalipassi LR; Malkin MD
Arch Gen Psychiatry; 1974 Jan; 30(1):102-5. PubMed ID: 4587065
[No Abstract] [Full Text] [Related]
24. Amantadine in the management of extrapyramidal side effects.
Borison RL
Clin Neuropharmacol; 1983; 6 Suppl 1():S57-63. PubMed ID: 6139167
[No Abstract] [Full Text] [Related]
25. No evidence of antipsychotic effect of caerulein in schizophrenic patients free of neuroleptics: a double-blind cross-over study.
Lotstra F; Verbanck P; Mendlewicz J; Vanderhaeghen JJ
Biol Psychiatry; 1984 Jun; 19(6):877-82. PubMed ID: 6378259
[No Abstract] [Full Text] [Related]
26. Medicated chronic schizophrenic patients do not demonstrate left turning asymmetry.
Levine J; Martine T; Feraro R; Kimhi R; Bracha HS
Neuropsychobiology; 1997; 36(1):22-4. PubMed ID: 9211440
[TBL] [Abstract][Full Text] [Related]
27. Treatment of schizophrenia with anticholinergic medications.
Tandon R; Dequardo JR
Am J Psychiatry; 1995 May; 152(5):814-5. PubMed ID: 7794374
[No Abstract] [Full Text] [Related]
28. Loxapine: a six-month evaluation in severely ill schizophrenic patients.
Gallant DM; Bishop G; Steel CA; Bishop MP
Curr Ther Res Clin Exp; 1973 Apr; 15(4):205-9. PubMed ID: 4633281
[No Abstract] [Full Text] [Related]
29. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
Neu C; Dimascio A; Demirgian E
Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
[No Abstract] [Full Text] [Related]
30. Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia.
Ogino S; Miyamoto S; Tenjin T; Kitajima R; Ojima K; Miyake N; Funamoto Y; Arai J; Tsukahara S; Ito Y; Tadokoro M; Anai K; Tatsunami S; Kubota H; Kaneda Y; Yamaguchi N
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):78-83. PubMed ID: 20828595
[TBL] [Abstract][Full Text] [Related]
31. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
[No Abstract] [Full Text] [Related]
32. Effect of amantadine (Viregyt-K) on extrapyramidal symptoms of parkinsonian patients.
Boczán G
Ther Hung; 1974; 22(4):147-53. PubMed ID: 4465958
[No Abstract] [Full Text] [Related]
33. A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
Salimi S; Fotouhi A; Ghoreishi A; Derakhshan MK; Khodaie-Ardakani MR; Mohammadi MR; Noorbala AA; Ahmadi-Abhari SA; Hajiazim M; Abbasi SH; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):726-32. PubMed ID: 18096287
[TBL] [Abstract][Full Text] [Related]
34. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
[TBL] [Abstract][Full Text] [Related]
35. Amantadine.
Parkes D
Adv Drug Res; 1974; 8():11-81. PubMed ID: 4219097
[No Abstract] [Full Text] [Related]
36. Delirium caused by intramuscular administration of biperiden.
Shinohara Y
J Neuropsychiatry Clin Neurosci; 2010; 22(2):E15. PubMed ID: 20463129
[No Abstract] [Full Text] [Related]
37. Effect of anticholinergic medication on positive and negative symptoms in medication-free schizophrenic patients.
Tandon R; Mann NA; Eisner WH; Coppard N
Psychiatry Res; 1990 Mar; 31(3):235-41. PubMed ID: 2333355
[TBL] [Abstract][Full Text] [Related]
38. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
Kammerer T; Schweitzer-Bucher E; Jamet P; Royer M
Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
[No Abstract] [Full Text] [Related]
39. An open-label trial of discontinuing benzodiazepines in patients with chronic schizophrenia.
Nakajima S; Uchida H; Suzuki T; Tomita M; Tsunoda K; Kitta M; Takeuchi H; Nomura K; Watanabe K; Kashima H
J Clin Psychopharmacol; 2007 Aug; 27(4):401-3. PubMed ID: 17632230
[No Abstract] [Full Text] [Related]
40. The double-blind sham-controlled study of high-frequency rTMS (20 Hz) for negative symptoms in schizophrenia: negative results.
Novák T; Horácek J; Mohr P; Kopecek M; Skrdlantová L; Klirova M; Rodriguez M; Spaniel F; Dockery C; Höschl C
Neuro Endocrinol Lett; 2006; 27(1-2):209-13. PubMed ID: 16648775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
